Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QMS Medical Allied ServicesNSE:QMSMEDI +5.00%69 5-Year Yield-on-Cost % is 0.34 as of Aug. 24, 2026, which is 28% below its 10-year median of 0.47. GuruFocus rates NSE:QMSMEDI with a GF Score™ of 69/100 and a GF Value™ of ₹121.42 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 315 Medical Devices & Instruments companies, QMS Medical Allied Services ranks worse than 91.75% on this metric.
The historical rank and industry rank for QMS Medical Allied Services's 5-Year Yield-on-Cost % or its related term are showing as below:
NSE:QMSMEDI'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.28 Med: 0.47 Max: 0.69
Current: 0.34
During the past 7 years, QMS Medical Allied Services's highest Yield on Cost was 0.69. The lowest was 0.28. And the median was 0.47.
NSE:QMSMEDI's 5-Year Yield-on-Cost % is ranked worse than 91.75% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.45
vs NSE:QMSMEDI: 0.34
QMS Medical Allied Services (NSE:QMSMEDI) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
QMS Medical Allied Services 5-Year Yield-on-Cost % Related Terms
NSE:QMSMEDI vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QMS Medical Allied Services 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where QMS Medical Allied Services's 5-Year Yield-on-Cost % falls into.
QMS Medical Allied Services 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
QMS Medical Allied Services (NSE:QMSMEDI) has a 5-Year Yield-on-Cost % of 0.34 as of Aug. 24, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on QMS Medical Allied Services and its competitors. This is 28% below median its historical median of 0.47. Over the past decade, QMS Medical Allied Services' 5-Year Yield-on-Cost % has ranged from 0.28 to 0.69. According to the industry distribution chart, QMS Medical Allied Services ranks #289 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 91.7%.
Is QMS Medical Allied Services' 5-Year Yield-on-Cost % too high?
QMS Medical Allied Services' current 5-Year Yield-on-Cost % of 0.34 is 28% below median its 10-year median of 0.47. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 0.69. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.45. QMS Medical Allied Services' value of 0.34 is 86.1% below this industry median. Based on the distribution chart, QMS Medical Allied Services ranks #289 out of 315 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, QMS Medical Allied Services has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does QMS Medical Allied Services' 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, QMS Medical Allied Services ranks #289 out of 315 companies for 5-Year Yield-on-Cost %. This places QMS Medical Allied Services in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.45. QMS Medical Allied Services' value of 0.34 is 86.1% below this benchmark. Historically, QMS Medical Allied Services' own 5-Year Yield-on-Cost % has ranged from 0.28 to 0.69 over the past decade. While the company's 10-year median is 0.47 vs. the industry median of 2.45, QMS Medical Allied Services has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.45, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QMS Medical Allied Services's current 5-Year Yield-on-Cost % of 0.34 is 86.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on QMS Medical Allied Services and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QMS Medical Allied Services's current 5-Year Yield-on-Cost % is 0.34, which is 28% below median its own 10-year median of 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QMS Medical Allied Services stock overvalued right now?
Based on GuruFocus' analysis, QMS Medical Allied Services (NSE:QMSMEDI) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹121.42, compared to a current price of ₹148.39 — trading 22.2% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.34, which is 28% below median its 10-year median of 0.47 and 86.1% below the Medical Devices & Instruments industry median of 2.45. QMS Medical Allied Services' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For QMS Medical Allied Services (NSE:QMSMEDI), the current 5-Year Yield-on-Cost % is 0.34 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?
Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be overvalued.
The current stock price of ₹148.39 is trading 22.2% above its estimated GF Value™ of ₹121.42.
GuruFocus considers QMS Medical Allied Services to be Modestly Overvalued.
Key valuation signals for NSE:QMSMEDI:
5-Year Yield-on-Cost %: 0.34 (28% below median its 10-year median of 0.47)
GF Value™: ₹121.42 vs. price of ₹148.39 (22.2% above fair value)
Industry Position: 86.1% below the Medical Devices & Instruments median (#289 of 315)
No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
69GF Score
Get the complete analysis for NSE:QMSMEDI
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QMSMEDI has been successfully added to your 
